• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL1300044 重组人源抗TNF-α单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2013-07-17 江苏众合医药科技有限公司 Jiangsu Zhonghe Pharmaceutical Technology Co Ltd Certificate Issued 2016-05-12 view